In Alzheimer’s disease, upregulated MAM function [64] leads to mitochondrial calcium overload, excessive ROS production and impaired lipid metabolism, impacting Aβ production and aggregation [65]. Here, SGCG is linked to early-onset autosomal dominant Alzheimer disease.